CohBar, Inc.
CWBRDelisted Dec 27, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001522602
CohBar, Inc. was delisted on Dec 27, 2023; its insiders filed their last Form 4 on Aug 3, 2022; 20 institutions reported holding it in 13F filings for Q1 2023, worth $135.4K in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by CohBar, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for CohBar, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Biunno Jeffrey Francis | CFO, Treasurer and Secretary | 57,355 | Aug 3, 2022 | 0 |
| Sarret Joseph J. | Chief Executive Officer | 151,017 | Aug 3, 2022 | 0 |
| Tozzo Stephanie | Director | – | Jul 12, 2022 | 0 |
| Greenwood David | Director | 40,000 | Nov 2, 2021 | 0 |
| Barzilai Nir Yacov | Director | 5,075,405 | Nov 2, 2021 | 0 |
| Petkevich Misha | Director | 407,609Indirect | Nov 1, 2021 | 0 |
| Yun Joanne | Director | – | Sep 15, 2021 | 0 |
| Nast Carol | Director | – | Aug 17, 2021 | 0 |
| Cundy Kenneth C | Chief Scientific Officer | 10,000 | Aug 13, 2021 | 0 |
| Amatruda John | Director | – | Jul 8, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 2, 2021 (view filing) | Nov 1 | 1 day | Greenwood DavidDirector | PPurchase | +20.0K | – | – | +100.0%40.0K after | |
| Nov 2, 2021 (view filing) | Nov 1 | 1 day | Greenwood DavidDirector | PPurchase | +20.0K | – | – | –35.0K after | Derivative |
| Nov 2, 2021 (view filing) | Nov 1 | 1 day | Barzilai Nir YacovDirector | PPurchase | +13.9K | – | – | +0.3%5.08M after | |
| Nov 2, 2021 (view filing) | Nov 1 | 1 day | Barzilai Nir YacovDirector | PPurchase | +13.9K | – | – | –13.9K after | Derivative |
| Nov 1, 2021 (view filing) | Oct 28 | 4 days | Petkevich MishaDirector | PPurchase | +167.0K | $0.58 | +$96.9K | +69.4%407.6K after | |
| Aug 19, 2021 (view filing) | Aug 18 | 1 day | Sarret Joseph J.Chief Executive Officer | PPurchase | +20.0K | $1.12 | +$22.4K | New position20.0K after | |
| Aug 13, 2021 (view filing) | Aug 11 | 2 days | Cundy Kenneth CChief Scientific Officer | SSale | −10.0K | $2.01 | −$20.1K | −50.0%10.0K after |